Search Results - "Infectious diseases now"

Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? by Cohen, Robert, Ashman, Marion, Taha, Muhamed-Kheir, Varon, Emmanuelle, Angoulvant, François, Levy, Corinne, Rybak, Alexis, Ouldali, Naim, Guiso, Nicole, Grimprel, Emmanuel

“…•Since the beginning of the COVID-19 pandemic, a decreased incidence of many viral and bacterial infections has been reported in children.•Non-pharmaceutical…”
Get full text

High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19 by Simonnet, A., Engelmann, I., Moreau, A.-S., Garcia, B., Six, S., El Kalioubie, A., Robriquet, L., Hober, D., Jourdain, M.

“…•Reactivations of EBV, CMV and HHV-6 are frequent in severe COVID-19.•EBV reactivation is associated with longer ICU length-of-stay.•EBV reactivation occurs…”
Get full text

COVID-19 vaccine hesitancy among healthcare workers by Paris, Christophe, Bénézit, François, Geslin, Mareva, Polard, Elisabeth, Baldeyrou, Marion, Turmel, Valérie, Tadié, Émilie, Garlantezec, Ronan, Tattevin, Pierre

“…•When COVID-19 vaccines became available in France, more than one quarter of healthcare workers (HCWs) were either hesitant (23%) or reluctant (4%) to be…”
Get full text

Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient by Bellanger, A.-P., Navellou, J.-C., Lepiller, Q., Brion, A., Brunel, A.-S., Millon, L., Berceanu, A.

Get full text

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 by Maisa, A., Spaccaferri, G., Fournier, L., Deniau, J., Rolland, P., Coignard, B., Andrieu, A., Broustal, O., Chene, S., Chent, S., Fougère, E., Lamy, A., Mano, Q., Mastrovito, B., Modenesi, G., Picard, G., Prudhomme, J., Rapilly, F., Rivière, M., Villegas Ramirez, B., Zurbaran, M., Bal, A., Beaurepere, R., Behillil, S., Belec, L., Bouri, L., Bressollette-Bodin, C., Brichler, S., Cado, S., Calvez, V., Castelain, S., Castro-Alvarez, J., Charpentier, C., Che, D., Chillou, C., Colson, P., Coudene, P., De Rougemont, A., Delagrèverie, H., Delamare, C., Descamps, D., Desroches, M., Destras, G., Dos Santos, G., Ducancelle, A., Ducreux, S., Duret, T., Enouf, V., Felici, C., Fourati, S., Fournier, P.-E., Gaudy, C., Germain, H., Giordanengo, V., Gorge, O., Haim-Boukobza, S., Henquell, C., Houhamdi, L., Izopet, J., Jacomo, V., Jaffar-Bandjee, M.-C., Jimenez, M., Josset, L., Kemeny, S., Le Bars, A., Le Corguille, G., Levasseur, A., Leveque, N., Lina, B., Madelaine, C., Malabat, C., Marque-Juillet, S., Martin-Dunavit, T., Mavingui, P., Merens, A., Morand-Joubert, L., Neybecker, P., Pawlotsky, J.-M., Plantier, J.-C., Pretet, M., Ragot, C., Raoul, H., Roque-Afonso, A.-M., Roquebert, B., Rousset, D., Sagot, C., Sahnoune, S., Sand, O., Saudemont, C., Schvoerer, E., Simon-Loriere, E., Stephan, R., Sudour, J., Thibault, V., Tuaillon, E., Vallee, E., Van Der Werf, S., Van Helden, J., Verdurme, L., Wilkinson, D.

“…•89% of investigated Omicron cases were symptomatic with mild symptoms.•64% of investigated Omicron cases were vaccinated with two doses.•9% and 8.3% of cases…”
Get full text

COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants by Hernández-Aceituno, Ana, García-Hernández, Abigail, Larumbe-Zabala, Eneko

“…•The Omicron variant was associated with a lower risk of COVID-19long-term sequelae.•Severity of illness indicators increased the risk (ICU length of stay and…”
Get full text

Resurgence of symptomatic Mpox among vaccinated patients: First clues from a new-onset local cluster by Jamard, S., Handala, L., Faussat, C., Vincent, N., Stefic, K., Gaudy-Graffin, C., Maakaroun-Vermesse, Z., Lemaignen, A.

Get full text

Herpesvirus reactivation during severe COVID-19 and high rate of immune defect by Saade, A., Moratelli, G., Azoulay, E., Darmon, M.

“…•High rates of acquired infections have been reported in severe COVID-19 patients.•We performed a competing risk analysis and used Fine and Gray model to…”
Get full text

The crisis of carbapenemase-mediated carbapenem resistance across the human–animal–environmental interface in India by Das, Surojit

“…•Overuse of carbapenems in human is expediting the cumulative burden of AMR in developing countries.•Carbapenem resistance, especially due to NDM circulates…”
Get full text

The outbreak of seasonal influenza after the COVID-19 pandemic in China: Unraveling the "Immunity debt" by Pan, Qingchun, Chen, Xiaohua, Yu, Yongsheng, Zang, Guoqing, Tang, Zhenghao

Get full text

Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients by Martinot, M., Eyriey, M., Gravier, S., Bonijoly, T., Kayser, D., Ion, C., Mohseni-Zadeh, M., Camara, S., Dubois, J., Haerrel, E., Drouaine, J., Kaiser, J., Ongagna, J.C., Schieber-Pachart, A., Kempf, C.

“…•In March 2020, 25% of patients with COVID-19 were admitted to the intensive care unit (ICU) and 19% died.•The main clinical factors associated with death were…”
Get full text

Diagnostic accuracy of a rapid antigen triple test (SARS-CoV-2, respiratory syncytial virus, and influenza) using anterior nasal swabs versus multiplex RT-PCR in children in an emergency department by Ferrani, Salim, Prazuck, Thierry, Béchet, Stéphane, Lesne, Fabien, Cohen, Robert, Levy, Corinne

“…•The performance of the triplex test (SARS-CoV-2, RSV and influenza) showed promising results.•The triplex test was performed with an anterior nasal swab.•For…”
Get full text

The presumed receptivity and susceptibility to monkeypox of European animal species by Haddad, Nadia

“…•Monkeypox virus is responsible for an outbreak outside the African continent..•It is a zoonosis, with possible interhuman transmission, which is exclusive in…”
Get full text

Changing profile of encephalitis: Results of a 4-year study in France by Mailles, A., Argemi, X., Biron, C., Fillatre, P., De Broucker, T., Buzelé, R., Gagneux-Brunon, A., Gueit, I., Henry, C., Patrat-Delon, S., Makinson, A., Piet, E., Wille, H., Vareil, M.O., Epaulard, O., Martinot, M., Tattevin, P., Stahl, J.P.

“…•The epidemiology of infectious encephalitis in France has changed over the last 15years.•Arboviruses increased widely, due to the spread of tick-borne…”
Get full text

Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population by Lapidus, Nathanael, Paireau, Juliette, Levy-Bruhl, Daniel, de Lamballerie, Xavier, Severi, Gianluca, Touvier, Mathilde, Zins, Marie, Cauchemez, Simon, Carrat, Fabrice

“…•During the first wave of the pandemic in France, the estimated overall infection hospitalization ratio (IHR, probability of hospitalization in infected…”
Get full text

2022 SPILF - Clinical Practice guidelines for the diagnosis and treatment of disco-vertebral infection in adults by Lacasse, M., Derolez, S., Bonnet, E., Amelot, A., Bouyer, B., Carlier, R., Coiffier, G., Cottier, J.P., Dinh, A., Maldonado, I., Paycha, F., Ziza, J.M., Bemer, P., Bernard, L., Bart, Géraldine, Coquerelle, Pascal, Corvec, Stéphane, Cotten, Anne, Couderc, Marion, Denes, E., Dupeyron, Arnaud, Godot, Sophie, Grare, Marion, Homs, A., Lam, Brigitte, Philippe Lavigne, Jean, Lemoing, V., Pertuiset, Edouard, Ribinik, P., Roblot, France, Senneville, Eric, Philippe Talarmin, Jean, Tavares Figueiredo, I., Titeca, Marie, Zeller, Valérie

“…These guidelines are an update of those made in 2007 at the request of the French Society of Infectious Diseases (SPILF, Société de Pathologie Infectieuse de…”
Get full text

Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosis by Maitre, Thomas, Baulard, Alain, Aubry, Alexandra, Veziris, Nicolas

“…Antibiotic-resistant tuberculosis continues to be one of the major threats to global tuberculosis control. After a hiatus of over 40 years in antituberculosis…”
Get full text

Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up by Seang, S., Itani, O., Monsel, G., Abdi, B., Marcelin, A.G., Valantin, M.A., Palich, R., Fayçal, A., Pourcher, V., Katlama, C., Tubiana, R.

“…•At 6 months, 30% of long COVID-19 non-severe patients completely recovered.•In this long COVID-19 outpatient cohort, the proportion of patients with more than…”
Get full text

Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia by Yildiz, Hanifi, Alp, Hamit Hakan, Ekin, Selami, Arisoy, Ahmet, Gunbatar, Hulya, Asker, Selvi, Cilingir, Buket Mermit, Sunnetcioglu, Aysel, Celikel, Masuk, Esen, Nevzat, Bedirhanoglu, Serhat, Baykal, Nuruban Delal, Haylu, Mine

“…•Serum levels of CoQ10, NOX4, MDA, and IMA which can be used as biomarkers of endogenous oxidative damage were significantly increased in patients with…”
Get full text

Determinants of COVID-19 vaccine hesitancy in French hospitals by Navarre, C., Roy, P., Ledochowski, S., Fabre, M., Esparcieux, A., Issartel, B., Dutertre, M., Blanc-Gruyelle, A.-L., Suy, F., Adelaide, L., Pariset, C., Kisterman, J.P., Champagne, H., Saison, J.

“…•Almost 50% of hospital workers were COVID-19 vaccine hesitant.•Women, non-medical, younger, and private sector workers showed greater hesitancy.•Specific…”
Get full text